• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Remdesivir resistance in transplant recipients with persistent COVID-19

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2022 Sep 26;ciac769.
doi: 10.1093/cid/ciac769. Online ahead of print.
Remdesivir resistance in transplant recipients with persistent COVID-19


John I Hogan[SUP] 1 [/SUP], Ralf Duerr[SUP] 2 [/SUP], Dacia Dimartino[SUP] 3 [/SUP], Christian Marier[SUP] 3 [/SUP], Sarah E Hochman[SUP] 4 [/SUP], Sapna Mehta[SUP] 4 [/SUP], Guiqing Wang[SUP] 5 [/SUP], Adriana Heguy[SUP] 5 [/SUP]



Affiliations

Abstract

New mutations conferring resistance to SARS-CoV-2 therapeutics have important clinical implications. We describe the first cases of an independently acquired V792I RNA-dependent RNA polymerase mutation developing in renal transplant recipients after remdesivir exposure. Our work underscores the need for augmented efforts to identify concerning mutations and address their clinical implications.

Keywords: Antiviral Resistance; Immunocompromise; Remdesivir; Rituximab; Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2); Solid Organ Transplant.
 
Back
Top Bottom